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Lipid membrane fusion is an essential function in many biological processes. Detailed
mechanisms of membrane fusion and the protein structures involved have been mainly
studied in eukaryotic systems, whereas very little is known about membrane fusion in pro-
karyotes. Haloarchaeal pleomorphic viruses (HRPVs) have a membrane envelope decorated
with spikes that are presumed to be responsible for host attachment and membrane fusion.
Here we determine atomic structures of the ectodomains of the 57-kDa spike protein VP5
from two related HRPVs revealing a previously unreported V-shaped fold. By Volta phase
plate cryo-electron tomography we show that VP5 is monomeric on the viral surface, and we
establish the orientation of the molecules with respect to the viral membrane. We also show
that the viral membrane fuses with the host cytoplasmic membrane in a process mediated by
VP5. This sheds light on protein structures involved in prokaryotic membrane fusion.
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Lipid membrane fusion is usually driven by membrane-associated proteins that confer specificity and overcome theenergy barriers related to the fusion process1. There is a
wealth of information about the mechanisms and the protein
structures involved in eukaryotic membrane fusion. In particular,
extensive studies of enveloped viruses infecting eukaryotes have
led to their assignment into three structural classes I–III. In
contrast, very few examples of enveloped viruses that infect
prokaryotes have been characterized. A notable example is the
enveloped bacteriophage φ6, which fuses with the outer mem-
brane of its Gram-negative host by a structurally unknown
mechanism2.
Haloarchaeal pleomorphic viruses (HRPVs) infect archaeal
hosts living in hypersaline environments. The newly established
family Pleolipoviridae includes several HRPVs with Halorubrum
pleomorphic virus 1 (HRPV-1) as the typical member3. The
virions contain two major protein species, a spike protein (VP4
and VP4-like proteins) protruding from the membrane surface
and a smaller membrane associated protein (VP3 and VP3-like
proteins) residing mostly inside the virion4,5. The genomes of
pleolipoviruses consist of either single- or double-stranded DNA
molecules which are not associated with any protein5,6. The VP4
spike protein of HRPV-1 is a type I transmembrane protein (with
an N-terminal signal peptide sequence of ~33 amino acids)4, N-
glycosylated with a pentasaccharide containing legionaminic acid
as the terminal residue and suggested to be involved in the host
recognition7 whereas for other pleolipovirus spike proteins, gly-
can modifications have not been detected.
In the absence of atomic structures for the spike proteins from
enveloped viruses infecting prokaryotes, it is unknown whether
they contain fusion proteins that are similar to those character-
ized in eukaryotic viruses. Pleolipovirus VP4-like surface spike
proteins are good candidates to be involved in membrane fusion5,
however their structure and function remains to be established.
The structure on the native virion and the distribution of the
VP4-like proteins on the virion envelope also remain unknown.
Here we describe crystallographic structures of VP4-like spike
proteins from two pleolipoviruses, HRPV-2 and HRPV-6,
showing that these proteins have a unique fold, different from
class I–III fusion proteins. By cryo-electron tomography utilizing
Volta phase plates we show that the spike protein of HRPV-6 is
monomeric on the surface of the virion. Fluorescence-based
assays demonstrate that the spikes induce fusion of the viral
membrane with the host cell membrane. In addition, we provide
preliminary evidence that the membrane fusion may be preceded
by a conformational change in the spikes. Together, our structural
and functional analysis of the VP4-like spike proteins and virions
allows us to suggest a model of prokaryotic virus-cell membrane
fusion.
Results
Pleolipovirus spike structures reveal a V-shaped fold. In order
to characterize the VP4-like fusion proteins (termed VP5 in these
viruses) from HRPV-2 and HRPV-6, we purified them from
infection-competent virions using either detergent (HRPV-2) or
protease digestion (HRPV-6). After protein purification, we
determined the structures of the HRPV-2 and HRPV-6 VP5
ectodomains (residues 1-498 out of 533 residues and 9-498 out of
537 residues, Supplementary Figure 1) at 2.5 and 2.7 Å resolution,
respectively, by X-ray crystallography (Table 1). The two proteins,
which are 67% identical in amino acid sequence (Supplementary
Figure 1), share a highly conserved V-shaped fold (r.m.s.d. for
453 corresponding Cα atoms: 1.6 Å) (Fig. 1a). The structure is
composed of two elongated domains roughly equal in size and
linked by a single residue (Q258 in HRPV-2 and Q262 in HRPV-
6) (Fig. 1a). The N-terminal domain comprises two subdomains
(N1 and N2) while the C-terminal domain includes three sub-
domains (C1–C3) (Fig. 1b).
The N-terminal subdomain, N1, contains a bundle of four α-
helices, one of which, α3, spans more than 40 residues (Fig. 1b).
Interacting with helix α3 of the helix bundle, subdomain N2 is
composed of three small β-sheets of two or three strands each.
Subdomain N2 is the least conserved between HRPV-2 and
HRPV-6 and amongst other pleolipoviruses (Fig. 1c; Supplemen-
tary Figure 1).
Previously we have determined the N-terminal sequences of
the ectodomains of both HRPV-2 and HRPV-6 VP5 proteins6.
The first twenty N-terminal residues of both VP5s are hydro-
phobic and predicted, by several programs for analysing
hydrophobic regions of proteins (see Methods), to form a
transmembrane helix, indicating the preference of this region to
partition into membranes. Interestingly, this hydrophobic
segment is shielded from the solvent in both crystal structures
by the C-terminal domain. Such protection is typical for fusion
peptides or fusion loops in the pre-fusion forms of class I and II
fusion proteins8, where the shielding is conferred by another
chain, either of the same or different protein species.
One of the C-terminal subdomains is α-helical and the other
two are formed of β-strands (Fig. 1b). Surprisingly, the entire C-
terminal domain is disordered in one of the two molecules of the
asymmetric unit of HRPV-6 VP5. Although there is space in the
crystal lattice to accommodate this disordered domain, the bulk
of adjacent molecules prevents it from adopting the same
orientation with respect to the N-terminal domain seen in the
other copies of VP5. It appears that the N- and C-terminal
domains can flex with respect to each other in the face of crystal
packing forces.
The last 20 residues of both HRPV-2 and HRPV-6 VP5s are
predicted to form a transmembrane helix9. Analysis of proteinase
K treated HRPV-6 particles by LC-MS/MS resulted in the
identification of several peptides with core sequence FGVPGE-
VAV representing part of the predicted C-terminal
Table 1 X-ray data collection and refinement details
HRPV-6 VP5 HRPV-2 VP5
Data collection
Space group P6522 P212121
Cell dimensions
a, b, c (Å) 114.3, 114.3, 445.2 48.1, 93.2, 121.8





Rmerge 16.5 (198.3) 12.6 (40.0)
I / σI 17.4 (1.8) 10.2 (2.2)
Completeness (%) 99.9 (99.8) 81.4 (36.3)
Redundancy 25.8 (22.5) 4.6 (2.9)
CC1/2 0.99 (0.75) 0.98 (0.72)
Refinement
Resolution (Å) 82.35–2.69 81.25–2.46
No. of reflections





B-factors (Å2) 76.2 39.4
R.m.s. deviations
Bond lengths (Å) 0.009 0.008
Bond angles (°) 1.1 1.0
aValues in parentheses are for highest-resolution shell. Number of crystals: 1
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Fig. 1 The overall fold of VP5. a Cartoon representation of HRPV-2 VP5 (left) and HRPV-6 VP5 (right) coloured from the N-terminal (blue) to the C-
terminal (red). Residues Q258 and Q262 connecting the N- and C-terminal domains are shown as green spheres. b Cartoon and topology representation of
HRPV-2 VP5 coloured by domains. c Structural differences between the N2 domains of superposed HRPV-2 VP5 (green) and HRPV-6 VP5 (pink).
d Localization of the potential fusion peptide depicted as magenta sticks within HRPV-2 VP5 shown as grey cartoon
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transmembrane domain (Supplementary Figure 2). In contrast,
HRPV-2 VP5 was released intact from the virion by detergent
treatment. However, the last 35 residues are not visible in the
electron density.
VP5 is monomeric on the virion surface. To determine the low-
resolution structure and oligomeric state of VP5 on the HRPV-6
surface, we used cryo-electron tomography and sub-tomogram
averaging (Fig. 2a, b; Supplementary Figure 3; Supplementary
Table 1). This was facilitated by Volta phase plate technology10,
which provided sufficient contrast in the tomographic recon-
structions for identification and alignment of the relatively small
VP5 (~57 kDa) spikes (Figs. 2a and 3). Sub-tomogram averaging
of 8953 manually picked spikes resolved the VP5 structure in situ
at 16-Å resolution, as estimated by Fourier shell correlation
(0.143 threshold). Each virion (N= 247) had 35 ± 7 VP5 spikes
on the surface and each spike is a monomer with the character-
istic triangular shape reminiscent of that seen in the high-
resolution X-ray structures (Fig. 2c, d). In cryo-electron micro-
scopy, high concentrations of salt surrounding the particles
diminish the contrast, hence HRPV-6 virions had been quickly
diluted before vitrification. In control experiments, HRPV-6 data
collected without reducing the salt concentration showed that the
radial profile of the cylindrically averaged spikes has the same
height in high and low salt conditions (Fig. 3). Since there is
robust agreement between the high-salt X-ray structure and the
low-salt tomographic data, transient exposure to low-salt condi-
tions has no major effect on the spike conformation.
We fitted the VP5 X-ray structure into the 16-Å resolution
VP5 tomographic density as a rigid body (Fig. 2c). Although the
fitting is generally robust (cross-correlation coefficient 0.84), there
is additional density in the groove between the N- and C-terminal
domains, which slightly protrudes from the EM density (Fig. 2c),
suggesting that VP5 attached to the viral membrane may adopt a
more compact conformation than in the crystal. The C-terminus
is proximal to the viral membrane, consistent with the predicted
C-terminal transmembrane region anchoring VP5 to the
membrane. Density corresponding to the last 39 residues of
HRPV-6 VP5 is not observed: the 23 residues preceding the very
last two C-terminal asparagine residues correspond to the TM
domain, and the preceding 19 missing residues (glycine rich;
Supplementary Figure 1) would act to link the ectodomain to the
TM domain. In this model, rigid body fitting placed Val461 close
to the membrane but this assertion remains to be validated
experimentally. The variable, putative receptor binding
N2 subdomain is located at the top of the spike. The accurate
localization of the putative fusion peptide was hampered by the
relatively low resolution (16 Å) of the tomographic reconstruc-
tion. Further studies at higher resolution are required to
determine how the putative fusion peptide is shielded from







Fig. 2 Cryo-electron tomography studies of HRPV-6. a A slice through a 3D tomogram of HRPV‐6 reconstructed from tilt series data collected using a
Volta phase plate. The scale bar corresponds to 40 nm. b Reconstruction of an HRPV-6 virion. 41 VP5 spikes were found from a representative HRPV-6
virion by manual picking. The EM density was projected onto the aligned positions and orientations of these spikes. c VP5 crystallographic structure fitted
into its density solved by cryo-electron tomography and subtomogram averaging
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VP5-spikes induce fusion with host cell membranes. With the
aim to test whether pleomorphic archaeal viruses fuse their
membrane envelope with the host cytoplasmic membrane of cells
we established a lipid mixing assay by using haloarchaeal pleo-
morphic virus HRPV-6 labelled with a lipophilic dye, octadecyl
rhodamine B chloride (R18). Labelled viruses were added to the
host cell culture for fluorescence microscopy. Cells displayed
areas of diffuse fluorescence, indicating that the dye had spread
from the viral membrane into the cell membrane (Fig. 4). In some
cells, punctate fluorescent signals were also observed. These sig-
nals most likely corresponded to virions that were bound to the
cell surface, but had not yet made their way through the S-layer
and reached the cell membrane (Fig. 4c). As a control, we used
labelled HRPV-6 particles, which were treated with proteinase K
to proteolytically cleave and remove the spikes, but not the
smaller (14.5 kDa) membrane associated protein termed VP4 in
this virus. When these spikeless particles were used in equal
numbers (as measured by the total R18 fluorescence signal), no
fluorescent signal was observed in the cells (Fig. 4b). This verified
that viral surface spikes are required for transfer of fluorescence
from virions to the host cell membrane.
In vitro time resolved fusion assays based on fluorescent lipid
probes have been widely used to characterize fusion kinetics of
eukaryotic viruses11. To establish such an assay for haloarchaeal
viruses, we mixed R18-labelled HRPV-6 particles with cells and
monitored R18 de-quenching over time. When we incubated
HRPV-6 with its host cells Halorubrum sp. SS7-4, lipid mixing
over 10% could be observed at 37 °C, revealing a half-time for
fusion of 18.1 ± 1.8 min (n= 3, Fig. 5a, Supplementary Table 2).
To corroborate the specificity of the lipid mixing assay, various
control experiments were performed (Fig. 5a). Lipid mixing did
not occur when HRPV-6 was incubated with the host cells at 4 °C,
confirming the arrestment of membrane fusion. We further found
that lipid mixing did not occur with proteinase K digested
spikeless HRPV-6 particles, hence indicating that fusion was
induced by the viral VP5 spike protein (Fig. 5a). Finally, we found
that lipid mixing also did not occur when HRPV-6 was incubated
at 37 °C with Halorubrum sp. strain PV6, the host of HRPV-1,
suggesting the requirement of specific host factors to induce
membrane fusion at 37 °C.
After having established the specificity of the kinetic lipid-
mixing assay between HRPV-6 and host cells, we proceeded to
develop a cell-free fusion assay. To this end, we prepared
liposomes from the Halorubrum sp. SS7-4 host cells and
monitored HRPV-6-liposome fusion at 37 °C. As expected from
the inherent removal of host proteins during lipid extraction, no
lipid mixing could be observed under this condition (Fig. 5b).
Lipid mixing could be readily detected when we increased the
temperature to 55 °C, reported to decrease HRPV-1 infectivity by
partial denaturation4, with a half time for fusion of 12.1 ± 4 min
(n= 3, Fig. 5b, Supplementary Table 2). This was not the case
when spikeless HRPV-6 particles were incubated at 55 °C with the
liposomes, confirming that VP5 protein was required for the
merger of membranes. To further characterize the temperature of
heat-induced fusion, we examined fusion temperatures between
37 °C and 55 °C. Lipid mixing was not detected in the
temperature range from 37°C to 45 °C while at 50°C some
membrane fusion occurred, albeit at a much lower level than at
55 °C (Fig. 5c). These data together confirm that HRPV-6 infects
cells by virus-cell membrane fusion induced by its VP5 spike
protein. Although host cell infection and fusion seems to depend
on stringent host cell factors in vivo, VP5 protein fusion
activation can be triggered through heating to 55 °C.
In order to test whether the heat treatment could trigger a
conformational change of the spikes occurring during fusion, we




























Fig. 3 Effect of NaCl concentration and the Volta-phase plate on the
tomographic data. a A slice through a 3D tomogram of HRPV-6 in 1.5M NaCl
buffer collected without Volta-phase plate. b A slice through a 3D tomogram
of HRPV-6 in 1.5M NaCl buffer collected with Volta-phase plate (left), and
the corresponding cross section of cylindrically average spike and density
distribution (right). c A slice through a 3D tomogram of HRPV-6 in 0.25M
NaCl buffer collected with Volta-phase plate (left), and the corresponding
cross section of cylindrically average spike and density distribution (right).
d Averaged radial density distributions of HRPV-6 in low (0.25M NaCl) and
high salt (1.5M NaCl) are compared. The radial density distribution for the
spike is similar at low- and high-salt concentration. The scale bar corresponds
to 100 nm. Source data are provided as a Source Data file
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EM. As shown in Fig. 6a, b, we can perceive extended spikes on
heat-treated HRPV-6 particles whilst such structures are not
observed on particles incubated at room temperature. Because
these particles were imaged at high salt, the contrast remains low.
Still, a conformational change was observed with spikes of one
virion in the sample imaged at low salt conditions (Fig. 6c). The
reason for this very rare event of spontaneous triggering is not
known. Thus, future studies are required to confirm and further
characterise such a conformational change.
Discussion
A wealth of information describing the mechanisms and the
protein structures involved in eukaryotic membrane fusion exists
for both cellular processes and infection by enveloped viruses1. In
contrast, prokaryotic membrane fusion has been studied only in a
few cases. One of these is the enveloped bacteriophage ϕ6 which
fuses its membrane with the outer membrane (OM) of the Gram-
negative host bacterium Pseudomonas syringae2. The viral protein
involved in this fusion process is embedded in the membrane and
as such represents an atypical fusion protein with as yet
uncharacterized atomic structure. Another class of prokaryotic
viral membrane fusion proteins are spanins which are periplasmic
proteins and have been suggested to fuse the Gram-negative host
cytoplasmic membrane (CM) with the OM consequently facil-
itating the lysis and exit of the virus progeny from the infected
cell12. While atomic structures of spanins are lacking, functional
analysis of phage lambda spanin suggests similarities to type I
fusion proteins13.
Our structural analysis of the pleolipovirus spike protein




Fig. 4 Microscopy of virus-cell fusion assay. Fluorescence microscopy of the Halorubrum sp. SS7-4 cells infected with fluorescently labelled HRPV-6 (a) or
fluorescently labelled spikeless HRPV-6 particles (b). c A close-up of cells infected with HRPV-6 showing spreading of fluorescence evenly along the cell
and viral particles fluorescing brightly. Pictures are representatives from at least three separate experiments all of which contained both treatments. Scale
bar 5 μm (a, b) and 2 μm (c). DIC, cells imaged using differential interference contrasting; R18, cells imaged using fluorescence for rhodamine label; merge,
































































HRPV-6 – TCPK+ SS7-4
HRPV-6 + SS7-4 (4 °C)
14 10 HRPV-6 55 °C
HRPV-6 45 °C
HRPV-6 50 °C
Fig. 5 Halorubrum virus membrane fusion. a HPRV-6 fusion kinetics with cells. Fluorescently labelled HRPV-6 was incubated at 37 °C with Halorubrum sp.
SS7-4 host cells (grey dots) or the non-host cells Halorubrum PV6 (white dots) at 37 °C under continuous stirring and dequenching measured at 585 nm.
As additional controls, HPRV-6 was incubated with Halorubrum sp. SS7-4 host cells at 4 °C (white boxes) or spikeless HRPV-6 was prepared by proteinase
K digestion (TCPK) and incubated with the same host cells at 37 °C (black triangles). b HPRV-6 fusion kinetics with liposomes derived from haloarchael
SS7-4 cell lipids. Fluorescently labelled HRPV-6 was incubated with liposomes at 37 °C (white boxes) and 55 °C (grey dots). As a control, spikeless HRPV-
6 was incubated with haloarchaeal liposomes at 55 °C (white triangles). Results from A and B are representative for n= 3 independent experiments. c Lipid
mixing kinetics of fluorescently labelled HRPV-6 particles after incubation with liposomes at 45 °C (black dots), 50 °C (white triangles) and 55 °C (grey
dots) normalized to the maximum extend of fusion at 55 °C. Each segmented line represent the single exponential fit to the kinetic data. Source data are
provided as a Source Data file
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elongated domains roughly equal in size. The structure is highly
conserved between the two VP5 proteins from two different
viruses and released from the virions using two different dis-
sociation methods. HRPV-2 and HRPV-6 VP5 proteins share an
average 67% amino acid sequence identity with the
N2 subdomain being the least conserved between the two spike
proteins. HRPV-2 and -6 infect different host strains suggesting
that domain N2 may play a role in host recognition. Furthermore,
fitting of the X-ray structure into the HRPV-6 VP5 tomographic
density positions N2 subdomain exposed to the surface of the
monomer. Thus, we hypothesize that the N2 subdomain is
responsible for the host receptor recognition. That question will
be the subject of future studies.
Using fluorescence microscopy we were able to show that the
lipophilic fluorescent label incorporated in the viral membrane
was spreading to the host cell membrane only during infection
with the wild-type particles and not with spikeless particles
containing the intact smaller structural protein VP4. In con-
cordance with this result, we demonstrated that lipid mixing
occurs during the infection of cells by HRPV-6 and that mem-
brane fusion can be induced with host-lipid derived liposomes
when HRPV-6 is incubated with liposomes at 55 °C. Such a heat-
induced activation based on partial protein denaturation has
previously been reported only for class I fusion proteins14,15.
In most known haloarchaeal species the cell wall consists of the
cell membrane covered by proteinaceous paracrystalline S-layer16,
a rigid layer which, however, has to be able to accommodate the
dynamics of transfer of molecules to and from the cell for cellular
responses and maintenance. The pleolipovirus in vivo fusion
mechanism may require an active interplay with the host S-layer
which most probably harbours the receptor for this archaeal
virus. The identity of the host receptor and the trigger for fusion
at physiological temperature remain an active area of
investigation.
On the basis of the present results, we propose a model for the
infection mechanism of haloarchaeal pleomorphic viruses
(Fig. 6d). Upon interaction of VP5 with the receptor on the host
cell surface, possibly via the N2 subdomain, the α-helical bundle
of N1 subdomain would open and extend ~150 Å due to inter-
actions with components of the glycoprotein S-layer. This might
further lead to opening of the surface layer allowing projection of
the putative fusion peptide towards the host cell membrane
(Fig. 6d), reminiscent of the large-scale conformational changes
observed in class I viral fusion proteins. The extended con-
formation would allow VP5 to reach across the ~120 Å thick S-
layer16. This hypothesis is supported by the evidence of HRPV-6
particles heated at 55˚C where the spikes seem to have switched
in a concerted fashion to an extended conformation (Fig. 6a, b).
The estimated maximum length of the filament-like spikes (190
Å) also matches our predictions of the maximum length of the
extended conformation of the spike (200 Å; Fig. 6d). This pre-
liminary observation of extended conformation of the spikes is
intriguing and will be addressed in the future by tomography and
sub-tomogram averaging.
Although many aspects of pleolipovirus fusion remain
uncharacterized, our results unequivocally highlight the role of
VP5 mediating fusion to enter its host cell. Only particles with
intact VP5 spikes could fuse their membranes with the host cell
and liposome, whereas VP5-free particles could not. VP5 is thus a
bona fide fusion protein. The monomeric fold of VP5 on the viral
particle surface is unlike all other known viral fusion proteins
which fall into one of three classes, I–III8. Other likely exceptions
to this classification are the still poorly understood and unclas-











Fig. 6 HRPV VP5 extended conformation and proposed model. a HRPV-6 virions incubated at room temperature do not show extended spikes. b HRPV-6
virions incubated at 55 °C, showing VP5 in more extended conformation. c A cryo-EM image showing a particle with extended spikes (low salt). Scale bars
correspond to 50 nm. d Proposed model for the rearrangement of HRPV spike from the pre-fusion to the membrane insertion step conformation. The N-
and C-terminal domains of VP5 are coloured in blue and red, respectively, whereas the putative host recognition (N2) domain is coloured in green. VP5
would bind to the host via its N2 domain and opens up an elongated structure of N1
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hepaciviruses17–20. We therefore propose that VP5 and related
pleolipovirus spike proteins are a different type of fusion proteins,
and may be the representatives of a previously unreported class of
viral fusion proteins. The unique features of these proteins may
reflect their similarity to a very ancient fusion mechanism
maintained in Archaea, the evolutionary pressure imposed by the
very high salt environment, and the presence of the thick pro-
teinaceous S-layer on the host surface. Further studies on mem-
brane fusion proteins of viruses infecting prokaryotes and
eukaryotes may illuminate the evolutionary connections between
the fusion proteins of prokaryotic and eukaryotic viruses.
Methods
Haloarchaeal host strains and viruses and growth conditions. Haloarchaeal
pleomorphic viruses HRPV-2 and HRPV-6 as well as their host strains Haloru-
brum sp. SS5-4 and SS7-4 were initially isolated from samples collected in a solar
saltern samples in Samuth Sakhon, Thailand21,22 and the non-pigmented derivative
of SS7-4 (see below), respectively, were used in this study. Halorubrum sp. PV65
was initially isolated from samples collected in a solar saltern in Trapani, Sicily, and
used as a non-host strain. Haloarchaeal strains were grown aerobically in Modified
Growth Media23 (MGM) at 37 °C. MGM broth, plates and soft-agar contained 23,
20 and 18% (wt v−1) artificial salt water (SW, HaloHandbook [http://www.
haloarchaea.com/resources/halohandbook/Halohandbook_2008_v7.pdf]) respec-
tively. Viruses were propagated on lawns of host cells grown in MGM soft agar.
HRPV-2 and HRPV-6 storage solutions were prepared using the top agar of semi-
confluent plates and incubating it together with MGM (2 ml for each plate used) at
37 °C with shaking for 2 h. The debris was removed by centrifugation (Sorvall F12,
11,000 × g for 40 min at 4 °C) and the cleared lysate was stored at 4 °C. 12% SW-
HEPES was diluted from the 30% SW-HEPES stock solution in which Tris-HCl
buffer (pH 7.2) was replaced by HEPES buffer of the same concentration and pH.
Production of non-pigmented mutant strain. Ethyl methane sulphonate (EMS)
was used to mutate cells of Halorubrum sp. SS7-4 and screen for non-pigmented
cells conducted as described by Mevarech and Werczberger24. Briefly, cells were
grown to exponential growth phase and collected by centrifugation (Sorvall SA600,
9700 × g at ambient temperature) followed by resuspension in an equal volume of
buffer containing 50 mM Tris-HCl pH 7.2 and 3M NaCl. EMS (Sigma M0880) was
added to the final concentration of 100 µg ml−1. Cells were incubated with EMS at
37 °C with aeration for 2 h after which cells were washed twice with the buffer.
Finally cells were resuspended in equal volume of MGM broth and grown until
they reached the density of ~1 × 109 cfu ml−1. Cell suspension was diluted and
plated on MGM media plates and grown at 37 °C until colonies appeared.
Purification of viruses and spike proteins. HRPV-6 and HRPV-2 virions were
purified from the storage solutions first by concentrating them with 10% poly-
ethylene glycol 6000 (PEG6000) at 4 °C for one hour with gentle stirring. Pre-
cipitated viral particles were collected by centrifugation (Sorvall F12, 11,000 × g at
4 °C) and viral pellets were resuspended in 18% SW. Aggregates were removed by
centrifugation (Sorvall F14, 11,500 × g at 4 °C). To obtain 1× purified virus, con-
centrated viral solution was subjected to rate-zonal centrifugation (104,000 × g at
15 °C for 2 h for HRPV-6 and for 3 h 30 min for HRPV-2, Sorvall AH629) in linear
5 to 20% (wt vol−1) sucrose gradient. The 1 × purified virus was further purified
with a CsCl gradient (ρ=1.3 g ml−1) by equilibrium centrifugation (79,000 × g for
20 h at 15 °C, Sorvall AH629) to obtain 2 × -purified material that was con-
centrated by centrifugation (114,000 × g for 3 h at 15 °C, Sorvall T647.5). For
crystallization of the spike proteins, two methods were used to dissociate and purify
the proteins directly from highly purified virions (2×-purified virus). For HRPV-2
VP5 protein, highly purified virions (200 µg ml−1) were dissociated with Nonidet
P40 at a final concentration of 0.1% (v v−1) in HRPV-buffer containing 20 mM
Tris-HCl pH 7.5, 1.5 M NaCl, 100 mM MgCl2 and 2 mM CaCl2. Soluble VP5
proteins were separated from the other dissociation products by rate zonal cen-
trifugation (Sorvall TH641, 210,000 × g, 4 h at 15 °C) in linear 5 to 20% sucrose
gradient in the HRPV-buffer. Soluble VP5 proteins were collected, concentrated
and washed with detergent removal buffer (20 mM Tris-HCl pH 7.5, 0.5 M NaCl)
using ultrafiltration (Amicon Ultra Centrifugal Filter Devices, Millipore, 10,000
nominal molecular weight limit). Detergent was removed from the sample using
Detergent Removal Spin Columns (Pierce) as instructed by the manufacturer.
Purified sample was washed with detergent removal buffer and concentrated by
ultrafiltration as described above.
The ectodomain of the HRPV-6 VP5 were released from highly purified virions
(2×virus, 200 µg ml−1) using proteinase K (Fermentas) digestion at a final
concentration of 20 µg ml−1 in 12% artificial salt water (SW). After the digestion (3
h, 37 °C) soluble ectodomains of the spike protein were separated from the other
dissociation products by rate zonal centrifugation (Sorvall AH629,112,400 × g, 7 h
at 15 °C) in a linear 5–20% sucrose gradient in 12% SW. Soluble proteins were
collected and concentrated by ultrafiltration (Amicon Ultra Centrifugal Filter
Devices, Millipore, 30,000 nominal molecular weight limit) and washed with gel
filtration buffer (20 mM Tris-HCl pH 7.2, 1 M NaCl, 40 mM MgCl2). The
ectodomains of the spike protein was separated from the remaining proteinase K
by gel filtration (Superdex 200, HiLoad 16/60, GE Healthcare) and fractions
containing the spike protein devoid of proteinase K were pooled, concentrated and
washed by ultrafiltration (Amicon Ultra Centrifugal Filter Devices, Millipore,
100,000 nominal molecular weight limit). The buffer of the final protein sample
contained 20 mM Tris-HCl pH 7.2, 1.6 M NaCl and 10 mM MgCl2.
Labelling of HRPV-6. Highly purified (2×-purified) HRPV-6 virions produced in
the non-pigmented SS7-4 host were labelled using R18 (O-246, Molecular Probes).
Approximately 1.7 × 1013 plaque forming units per millilitre (PFU ml−1) were
mixed well with 45 µg ml−1 (62 µM) of the lipophilic dye and divided in two
aliquots of equal volume. After one hour-incubation at 37 °C in dark, proteinase K
(Fermentas) was added to one aliquot at final concentration of 200 µg ml−1 and
both aliquots were incubated further for another 1 h at 37 °C. Virions were purified
by rate zonal centrifugation in a linear 5–20% sucrose gradient (Sorvall TH641,
154,000 × g for 3 h 30 min at 15 °C). Light scattering zones containing the virions
were collected, concentrated and washed by ultrafiltration (Amicon Ultra Cen-
trifugal Filter Devices, Millipore, 100,000 nominal molecular weight limit). The
infectivity of the labelled particles was determined by titration and the incor-
poration of fluorescent label by measuring the released fluorescence in counts
per second (cps) at Ex 560 nm and Em 590 nm in the presence of 0.17% Triton X-
100 (v v−1) in 12% SW-HEPES buffer using FluoroMax-4 spectrofluorometer
(HORIBA Jobin Yvon Inc). Specific infectivity was determined as plaque forming
units per counts of fluorescence in one second (PFU cps-1) and it was 72 PFU cps
−1 for the wild-type HRPV-6 particles and 8.0 × 10−2 PFU cps−1 for the spikeless
particles. Analysis of the viral particles in SDS-PAGE showed that most of the spike
protein was removed by the proteinase K digestion (Supplementary Figure 4).
Adsorption tests. The host culture to be tested was diluted to A550nm of 0.1 and
grown to an approximate cell density of 2–3 × 108 colony-forming units per mil-
lilitre (CFU ml−1, A550nm 0.45–0.5) at 37 °C with shaking (~16 h). Cells were
collected by centrifugation (Sorvall SA600, 9700 × g, 5 min, RT) and resuspended in
either MGM or 12% SW- HEPES. Viruses were added to the cell culture at mul-
tiplicity of infection (M.O.I.) of 6 × 10−7. Samples of 200 µl were withdrawn at
indicated time points, cells were collected by centrifugation (Eppendorf Centrifuge
5415D 9300 × g, 5 min, RT) and the supernatant and the cell pellet, resuspended in
200 µl of fresh growth medium, were titrated in 100 µl aliquots with host cells as
described before5.
Fluorescence microscopy. Non-pigmented haloarchaeal SS7-4 host cells produced
in this study (see Production of non-pigmented mutant strain) were grown as
described for the adsorption test. To a solution of cells at their logarithmic growth
phase (A550nm of ~0.4–0.5, ~1–2 × 108 CFU ml−1) labelled viruses were added at an
approximate M.O.I. of 10–50 (virions devoid of proteinase K treatment) and
approximately the same number of proteinase K-treated viral particles as deter-
mined by released fluorescence. Suspensions were incubated at 37 °C for 15 min
with shaking after which cells from 1ml of sample were collected by centrifugation
(Eppendorf Centrifuge 5415D, 5900 × g, 5 min, RT) and washed once with MGM
broth. Cells were incubated for additional 10 min after which the media was
changed into 12% SW-HEPES by pelleting and resuspension of the cells twice.
For microscopy, cells in 12% SW-HEPES were fixed with paraformaldehyde
(final concentration 5.2% v v−1) for 20 min and washed with 12% SW-HEPES
three times. Aliquots of fixed cell suspension were mounted on 1% agarose in 12%
SW-HEPES and visualised using a Leica DM6000B (Wezlar, Germany) microscope
with ×63/1.40 HCX PL APO Lbd.bl. oil objective with ×1.25 magnification changer.
Final pixel size is 69 nm. Differential interference contrasting (DIC) was used with
bright field and Semrock Brightline TRITC-B (ex 543/22, em 593/40) filter to detect
the fluorescence of R18. A Hamamatsu Orca Flash 4.0v2 camera was used to
capture 16 bit images. 700 ms exposure time was used for fluorescence channel
Leica Application Suite X (LAS X) and Fiji ImageJ 1.51n was used for image
processing. The fluorescence signal of all obtained images were adjusted to
maximal fluorescence of 1200 and within one experiment, images obtained from
DIC and fluorescent channels were all aligned manually in the same way.
Virus-cell and virus-liposome fusion assay. Virus fusion with target membranes
was monitored by fluorescence dequenching of R18-labelled virions by standard
techniques25. To this end, purified (1×-purified) HRPV-6 virions produced in the
non-pigmented Halorubrum sp. SS7-4 host were labelled with R18 at a self-
quenching concentration as described above. R18 labelled HRPV-6 virions were
separated from excess probe by using a sephadex G-75 column (GE Healthcare). As
a negative control, R18 labelled and purified HRPV-6 particles were treated with
proteinase K at 200 μg ml−1 for 1 h at 37 °C to eliminate any exposed membrane
proteins.
In the case of virus–cell fusion, non-pigmented haloarchaeal cells were used at
their logarithmic growth phase (OD 0.4–0.5, adsorption at 550 nm). For
virus–liposome fusion, total lipids were extracted from non-pigmented
haloarchaeal SS7-4 host cells based on one phase alcoholic solvent system based on
methanol-chloroform-water (1:2:0.8 v v‒1) extraction as described before26 and
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resuspended in HRPV buffer. Fresh liposomes were prepared by the freeze-thaw
and extrusion method27 using a polycarbonate filter with a pore size of 0.2 mm
(Avanti Polar Lipids).
To monitor fusion, R18 labelled HRPV-6 virions (~108 PFU) were mixed with
either non-pigmented haloarchaeal cells at a MOI of 10–20 or with liposomes
derived from SS7-4 host cells (5 mgml‒1) in a fluorimeter cuvette under continuous
stirring at the indicated temperatures. Fluorescence dequenching was recorded
continuously every 60 s at 585 nm at an excitation wavelength of 565 nm using a
fluorescence spectrophotometer (Varian Eclypse, Agilent Technologies) with 5 and
10-nm slit width for excitation and emission, respectably. The base value at time 0
was defined as 0% lipid mixing and the maximal extent of R18 dilution was
determined by the addition of Triton X-100 (final concentration 0.1%) after the
lipid mixing of each condition had concluded. After data collection, the lipid
mixing kinetic was fitted to a single exponential fit using Eq. (1).
Lipidmixing tð Þ¼ Lipidmixingmax ´ ð1 expðτ ´ tÞÞ ð1Þ
where τ is the time constant and Lipid mixing max corresponds to the maximum
lipid mixing value at infinitive time.
LC-MS/MS. Peptides were quenched with 10% trifluoroacetic acid (TFA) and
purified with C18 microspin columns (Harvard Apparatus, USA) eluting the
samples to 0.1% TFA in 50% acetonitrile (ACN). The dried peptides were recon-
stituted in 30 µl 0.1% TFA in 1% ACN (buffer A). Liquid chromatography coupled
to tandem mass spectrometry (LC-MS/MS) analysis was carried out on an EASY-
nLC 1000 (Thermo Fisher Scientific, Germany) connected to a Velos Pro-Orbitrap
Elite/Q Exactive hybrid mass spectrometer (Thermo Fisher Scientific, Germany)
with nano electrospray ion source (Thermo Fisher Scientific, Germany). The LC-
MS/MS samples were separated using a two-column setup consisting of a 2 cm C18
Pepmap column (#164946 Thermo Fisher Scientific, Germany), followed by 15 cm
C18 Pepmap analytical column (#164940 Thermo Fisher Scientific, Germany). The
linear separation gradient consisted of 5% buffer B in 5 min, 35% buffer B in 60
min, 80% buffer B in 5 min and 100% buffer B in 10 min at a flow rate of 0.3 µl min
−1 (buffer A: 0.1% TFA in 1% acetonitrile; buffer B: 0.1% TFA acid in 98%
acetonitrile). 4 µl of sample was injected per LC-MS/MS run and analysed. Full MS
scan was acquired with a resolution of 60,000 at normal mass range in the orbitrap
analyzer the method was set to fragment the 20/10 (QE 10 and OQ top 20) most
intense precursor ions with CID (Elite OE/HCD with QE) (energy 35). Data were
acquired using LTQ Tune software.
Acquired MS2 scans were searched against home-made protein database using
the Sequest search algorithms in Thermo Proteome Discoverer. Allowed mass error
for the precursor ions was 15 ppm. And for the fragment in 0.8 Da/or 0.05 Da(Q
Exactive). A static residue modification parameter was set for carbamidomethyl
+57,021 Da (C) of cysteine residue. Methionine oxidation was set as dynamic
modification +15,995 Da (M). The analysis was carried out at the Protein
Chemistry Core Laboratory, Institute of Biotechnology, Helsinki Institute of Life
Science HiLIFE, University of Helsinki.
Crystallization and data collection. Both HRPV-2 VP5 and HRPV-6 VP5 pro-
teins were crystallized in 96-well plates (Greiner Bio-One Ltd, Stonehouse, Eng-
land) using the sitting-drop vapour-diffusion method at 21 °C with a Cartesian
Technologies MIC4000 robot28,29 (Digilab). HRPV-2 VP5 crystals grew in a
solution containing 12% (w v−1) PEG 4000, 0.1 M Na-HEPES pH 7.5 and 0.1 M
NaCl from the MemSys crystallization screen (Molecular Dimensions). Crystals
were first stabilised in the same reservoir solution but containing 30% (w v−1) PEG
4K and then dipped into oil (Perfluoropolyether PFO-X175/08, Hampton
Research) before flash-cooling in liquid nitrogen. A dataset (space group P212121)
was collected on beamline I24 at Diamond Light Source (DLS, Didcot, England) to
2.5 Å resolution (unit cell a= 48.1, b= 93.2, c= 121.8 Å, α= β= γ= 90°). Initial
crystals of HRPV-6 VP5 grew in 1.6 M Ammonium Sulphate, 0.1 M Citrate pH 5.0
from the Ammonium Sulphate Grid Screen (Hampton Research) and were further
optimized by adjusting the pH between 5.4 and 5.8 and the precipitant between 1.6
and 1.8 M. Due to the high NaCl concentration in the protein buffer, NaCl was
added to all the reservoir solutions to a final concentration of 1.6 M. For phasing
purposes, HRPV-6 VP5 crystals were briefly immersed in the reservoir solution
containing 0.2 M NaBr and 30% (w v−1) ethylene glycol prior to flash-cooling in
liquid nitrogen. In order to optimize the anomalous signal from the bromine, a
dataset was collected close to the bromine edge at 0.9150 Å on the I02 beamline at
DLS employing the inverse-beam method. Crystals diffracted to 2.7 Å resolution
and belonged to space group P6522 with unit cell parameters a= b= 114.3, c=
445.2 Å, α= β= 90°, γ= 120°. HRPV-2 and HRPV-6 VP5 datasets were indexed,
integrated, and scaled with XIA230–32.
Structure determination and refinement. Structure determination of HRPV-6
VP5 via the single-wavelength anomalous dispersion (SAD) method used the
anomalous scattering from the bromine atoms. HKL2MAP33,34 determined the
position of 20 bromine atoms, which were then used in PHENIX.AUTOSOL35 for
phasing. The experimental electron density map was clearly interpretable and the
structure was initially partially built with PHENIX.AUTOBUILD35 and then
completed by manual building in COOT36. Two molecules were present in the
asymmetric unit, although no density could be seen for half of one of them. HRPV-
2 VP5 (62% sequence identity to HRPV-6 VP5) was solved by molecular repla-
cement using PHASER37 using HRPV-6 VP5 as a search model. Both structures
were refined with AUTOBUSTER38 to Rwork and Rfree of 21.8/23.3% for HRPV-6
VP5, and 22.4/24.1% for HRPV-2 VP5. Final structures were validated with
MOLPROBITY39 with more than 97% of residues in the Ramachandran favoured
regions and no outliers. Data collection and refinement details are presented in
Table 1, and a stereo view of the final electron density maps are shown in Sup-
plementary Figure 5.
Protein in silico analyses. The hydrophobic regions of HRPV-2 and HRPV-6 VP5
proteins were predicted using TMpred server9, Phobius40 and MPEx41.
Sample preparation for electron microscopy. VP5 spikes on HRPV-6 are very
sensitive to ionic strength and only stable in 1.6 M NaCl or above. At lower
concentrations of NaCl the spikes fall apart. As a result a careful optimisation of
NaCl concentration and incubation time was performed. For cryo-EM, samples
were prepared by diluting the purified virus (10×) in the buffer containing 250 mM
NaCl immediately prior vitrification. Aliquots of 4 μl were added onto a glow-
discharged holey carbon copper grid (C-flat, CF-2/1-2C; Protochips). Grids were
blotted for 3 s, in 90% relative humidity, and vitrified in liquid ethane with a
plunger device (Vitrobot; FEI). In order to keep the spikes intact and in native
form, grids were plunged within 30 s of dilution to low salt buffer. To assess the salt
concentration effect on the virions and spike, HRPV-6 in 1.5 M NaCl buffer were
plunge-frozen on the grids as control.
To study heat-treated particles of HRPV-6, 100 µl of highly purified particles
(~1 × 1012 pfu ml−1) were split into two 50 µl aliquots. One aliquot was incubated
at 55 °C and one at room temperature for 30 min in HRPV-buffer. Aliquots of 3 µl
were added onto glow-discharged copper quantifoil grids (R1.2/1.3), blotted for 4.5
s and vitrified in liquid ethane with a plunger device (Vitrification robot; Leica).
Cryo-electron microscopy data collection. Cryo-EM data were collected at the
national Electron Bio-Imaging Center (eBIC), at the Diamond Light Source on a
FEI Titan Krios transmission electron microscope operating at 300 kV. The Krios
was equipped with an energy filter (GIF Quantum, Gatan) operating in zero-loss
mode with a 20 eV slit and a Volta phase plate (VPP; Thermo Fisher). Single axis
tilt series (from ‒45° to+45° with angular increments of 3°) were collected using
EPU software (FEI) on a direct electron camera (K2 Summit, Gatan). At each tilt,
images were recorded as a movie consisting of eight frames with a total exposure of
1.6 s per tilt and at a calibrated magnification of ×22,222 in a single electron
counting mode, corresponding to a pixel size of 2.25 Å. The datasets were collected
in focus and the standard autofocusing routine implemented in EPU was used at
every tilt angle. Cumulative electron dose was kept constant in all datasets and the
irradiated area on the VPP was changed after each tomogram. Images of heat
treated particles were collected at the University of Helsinki cryo-EM facility on a
Talos Arctica electron microscope operating at 200 kV and using Falcon III
detector (Thermo Fisher).
Image pre-processing and tomogram generation. Drift correction42 was used to
correct for the electron beam induced motion by averaging eight frames for each
tilt. 25 tilt series were aligned by patch tracking in IMOD package43. The six best
tilt series, which showed consistent contrast, were reconstructed into tomograms
with a final pixel size of 2.25 Å. Altogether 247 HRPV-6 virions were picked in
Bshow44 and extracted from the tomograms using Jsubtomo45 for further analysis.
Sub-tomogram averaging. For initial template generation, extracted virion
volumes were low pass filtered to 80 Å using Bsoft44. Spikes (8953 in total) were
manually picked from the volumes of HRPV-6 using Dynamo46. All picked spikes
were extracted from the unfiltered tomograms into boxes of 128 × 128 × 128 voxels.
Sub-tomogram averaging was carried out in Dynamo46, following protocols we
have established earlier45,47. In the first stage of refinement, both the locations and
directions of the picked particles were allowed to change. The angle around the
spike long axis (azimuth) was kept fixed. The refinement was carried out while
restricting the resolution to 36 Å, during which a large spherical mask (radius 63
pixels) and full cylindrical symmetrization were applied to roughly align the spikes.
For the second stage, a customized post-processing plugin47 was designed to
carry out gold-standard refinements where only the azimuth angle was refined. The
dataset was randomly split into two datasets consisting of 4502 and 4451 particles
and each dataset was averaged to produce a template for refinement. Independent
refinements were carried out on the two datasets. At the end of each iteration, the
Fourier shell correlation (FSC) between the two averages was computed and the
resolution estimated using a criterion of 0.143. Two shells in Fourier space were
subtracted from the estimated resolution value, and the difference was used as the
threshold for a low-pass filter for the next iteration. A spherical mask (radius 32
pixel), encompassing only the spike ectodomain was used, and no symmetry was
assumed. After this stage, 1436 particles were removed from the dataset due to
overlaps. Averaging the remaining particles produced an ellipsoidal-shaped spike
density, which was connected with the membrane by one, possibly two small stalks.
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In the third stage, an ellipsoidal mask (semi-principal axes of length 40, 24 and
24 pixels in the x, y and z direction), encompassing only the spike ectodomain was
used. In this stage, the azimuth angle was further refined with small angular search
steps. After this stage, 629 particles were removed from the dataset due to low
cross-correlation. The coordinates of the remaining particles were plotted and 226
particles located obviously outside of the virus were further removed.
In the fourth stage, all six parameters (three location coordinates and three
Euler angles) were allowed to change simultaneously. After this stage, 741 particles
were removed due to low cross-correlation or overlap, giving finally 3112 and 2945
particles for the two datasets. The final map resolution of 16 Å was estimated by
FSC, using 0.143 as threshold. To assess the salt concentration effect on the virions
and spike, 1200 spikes from HRPV-6 in 1.5 M NaCl buffer were cylindrically
aligned and averaged.
X-ray structure fitting. X-ray structure of HRPV-6 VP5 was fitted as a rigid body
into the segmented EM density of the VP5 spike in UCSF Chimera48. Initial
manual fitting that placed the C-terminus proximal to the membrane was
improved by ‘fit in map’ function (correlation 0.83).
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Data supporting the findings of this manuscript are available from the corresponding
authors upon reasonable request. A reporting summary for this Article is available as a
Supplementary Information file. The source data underlying Figs. 3d, 4, 5, Supplemen-
tary Figure 2 and 3b are provided as a Source Data file. Coordinates and structure factors
of HRPV-2 VP5 and HRPV-6 VP5 have been deposited in the Protein Data Bank under
ID codes 6QGI and 6QGL, respectively. The accession ID for the EM map reported in
this paper is EMD-9779 and the PDB-code for fitted HRPV-6 VP5 is 6J7V. The MS/MS
data was submitted to PeptideAtlas with identifier PASS01324.
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